Pages that link to "Q36077401"
Jump to navigation
Jump to search
The following pages link to Important roles of reversible acetylation in the function of hematopoietic transcription factors. (Q36077401):
Displayed 11 items.
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents (Q21198868) (← links)
- MTA1, a transcriptional activator of breast cancer amplified sequence 3 (Q24546715) (← links)
- Drosophila histone deacetylase-3 controls imaginal disc size through suppression of apoptosis (Q28472324) (← links)
- Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2. (Q33883148) (← links)
- GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesis (Q36103531) (← links)
- Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. (Q36379368) (← links)
- Assays for pharmacodynamic analysis of histone deacetylase inhibitors (Q36546255) (← links)
- Epigenetic regulation of normal and malignant hematopoiesis (Q36970179) (← links)
- Modelling the microtubule: towards a better understanding of short-chain fatty acid molecular pharmacology. (Q37833936) (← links)
- Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. (Q42742238) (← links)
- Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia (Q83213851) (← links)